| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | Canada | 4 | |
| #4 | United States | 2 | |
| #5 | Hungary | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Acyclic or carbocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wang Zhaoyin | 15 |
| #2 | Berthelette Carl | 14 |
| #3 | Li Lianhai | 14 |
| #4 | Sturino Claudio F | 9 |
| #5 | Dufresne Claude | 7 |
| #6 | Lacombe Patrick | 6 |
| #7 | Aspiotis Renee | 6 |
| #8 | Guay Daniel | 6 |
| #9 | Gallant Michel | 6 |
| #10 | Sturino Claudio | 5 |
| Publication | Filing date | Title |
|---|---|---|
| AU2005206229A1 | Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors | |
| CA2554332A1 | Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events | |
| EP1601644A1 | Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors | |
| AU2003301109A1 | Pharmaceutical compositions and method of treating Parkinson's disease |